New Delhi [India], February 5: Deeptech startup Algorithmic Biologics (AlgoBio), leveraging advanced algorithms and AI to revolutionize molecular testing efficiency and scale, unveiled the Tapestry platform for next-generation sequencing (NGS) at Genomics India Conference 2024 today. Aligned
According to sources, Maharashtra has reported a maximum of 250 cases of JN.1 sub-variant of Covid-19, followed by Karnataka with 199 cases of the infection.
According to the Brigham researchers' next-generation sequencing, changing existing cancer care standards might allow around 6,000 more patients in the United States to benefit from immunotherapy treatment each year.
The national capital reported two new cases of coronavirus on Thursday and reports of both the infected patients were sent for genome sequencing to confirm whether they were instances of sub-variant, JN.1.
The national capital has reported two fresh cases of COVID-19, said the Medical Superintendent of All India Institue of Medical Science (AIIMS) hospital.
"On average, 400-500 samples are being tested every day in Delhi, and on average, 5-7 positive cases are coming; that is, the positivity is about one percent. As of today, a total of four Corona patients are in hospitals in Delhi. There is no situation of panic," said Bhardwaj.
As COVID cases show an upward trend in multiple states, reaching 3742 active patients on Sunday, concerns mount with the highest reported cases in Kerala, where a new variant, JN.1, has emerged.
A 62-year-old woman was isolated at Mahama Gandhi Memorial Hospital in Telangana after incidentally developing COVID-19 symptoms, JN.1 variant to be confirmed after genome sequencing, said Superintendent, MGM Hospital V Chandrashekar on Saturday.
The India SARS-CoV-2 Genomics Consortium (INSACOG), which is a multi-laboratory, multi-agency, pan-India network tasked with sequencing and keeping an eye on new threatening Covid-19 variants, has done surveillance where this variant has been found in Kerala.
San Diego [US], November 14: Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the launch of the Global Health Access Initiative to support access to pathogen sequencing tools for public health in low- and middle-income countries (L
Research from the Francis Crick Institute, the University of Cambridge, Imperial College London, the University of Liverpool, the University of Cape Town, and UKHSA has linked molnupiravir, an antiviral drug for COVID-19 infections, and a pattern of mutations in the SARS-CoV-2 virus.